Power Law company profile

Krystal Biotech

Biotech & Life Sciences · Pittsburgh, United States · Founded 2016 · IPO 2017 Unicorn

Makes a meaningful difference in the lives of underserved patient populations suffering from debilitating skin diseases

Valuation

$6.90B

Market cap · May/2026

Revenue

$389M

Latest reported FY

EBITDA

$227M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

5 investors on Krystal Biotech's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Sun Pharmaceutical Industries

Series B+ 4 investors entered at this stage

Frazier Healthcare Partners

Avoro Capital Advisors

Braidwell

Redmile Group

Global footprint

Where Krystal Biotech has talent and traffic

Workforce by country

7 countries with
team presence

🇺🇸 United States89.5%

🇨🇭 Switzerland3.6%

🇩🇪 Germany2.7%

🇯🇵 Japan1.7%

🇫🇷 France1.6%

Top 5 of 7 shown

Web traffic by country

16K monthly visits
across markets

🇺🇸 United States48.8%

🇮🇳 India23.8%

🇬🇧 United Kingdom10.6%

🇨🇦 Canada8.8%

🇪🇸 Spain5%

Top 5 markets shown

Patent intelligence

$30M patent portfolio · 21 active families

Estimated portfolio value

$30M

0.44% of market cap · 2.8× smaller than top peer Twist Bioscience ($84M)

21 active patent families

Where Krystal Biotech innovates PolynucleotideVirusNucleic acidDiseaseBioinformatics

Where Krystal Biotech concentrates vs peers

Each axis is a top-10 topic across Krystal Biotech and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Krystal Biotech

An AI-synthesized read of the highest-engagement posts about Krystal Biotech on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Krystal Biotech on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles